Blue Bell Private Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Blue Bell Private Wealth Management's TAK Position: Q3 2022 in Review
Blue Bell Private Wealth Management sold out of Takeda Pharmaceutical (TAK) in Q3 2022, closing a stake of 458 shares — an estimated $6K sold.
Blue Bell Private Wealth Management first reported a position in TAK in Q4 2021 and held it in 3 quarters. The position peaked at $7K in Q1 2022. 276 funds tracked by Wall St. Rank hold TAK as of Q3 2022.
- Blue Bell Private Wealth Management reported no remaining Takeda Pharmaceutical position as of Q3 2022 after selling out during the quarter.
- Blue Bell Private Wealth Management sold 458 Takeda Pharmaceutical shares in Q3 2022, an estimated $6K.
- Blue Bell Private Wealth Management first reported a position in Takeda Pharmaceutical in Q4 2021 and held it in 3 quarters.
- Blue Bell Private Wealth Management's Takeda Pharmaceutical position peaked at $7K in Q1 2022.
- 276 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2022.
Based on Blue Bell Private Wealth Management's 13F filing for Q3 2022, filed 9 Nov 2022.